Arkolith/Insider Trading/CYTK/Form 4

Lee Sung

EVP, Chief Financial OfficerCYTOKINETICS INC (CYTK) · full profile →Form 4 · filed Jun 29, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$266K
Net Open-Market Flow
-$266K
Transactions
11
6 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 29, 2026Option exercise(M)188$44.36$8K63K
Jun 29, 2026Option exercise(M)822$44.36$36K64K
Jun 29, 2026Option exercise(M)1K$48.51$54K65K
Jun 29, 2026Option exercise(M)188$44.36$8K66K
Jun 29, 2026Option exercise(M)823$44.36$37K66K
Jun 29, 2026Sell(S)3K$85.00$266K63K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 29, 2026Option exercise(M)188—$09K
Jun 29, 2026Option exercise(M)822—$041K
Jun 29, 2026Option exercise(M)1K—$052K
Jun 29, 2026Option exercise(M)188—$09K
Jun 29, 2026Option exercise(M)823—$040K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001061983-26-000070) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML